We are a passionate and diligent team working in the field of immunology. Come and see how we strive for excellence in research and dabble in fun! #goscience
The Walter lab joined #RunForAllChildren at JHACH on Saturday! We are grateful for our USF/JHACH AI team Building Bridges for coming out to share this moment 💚 #GoBulls
September is #NewbornScreening Awareness Month! We're sharing information about NBS for #SCID, our global #advocacy efforts, and family stories. In 2018, NBS for SCID was finally implemented across the USA. Learn more about the history of NBS at https://t.co/2udMfsrsVl 🧪
Excited to share our recent collaborative work regarding PIK3CD deficiency. Check us out!!😀
Cellular Mechanisms Underlying B Cell Abnormalities in Patients With Gain-of-Function Mutations in the PIK3CD Gene https://t.co/hb1LIMxeUR
🗣️🗣️ Please take a look at our recent publication on partial RAG deficiency
Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defec… https://t.co/z1FKfdT19W
Check out the Walter Lab's recent publication on a rare primary immunodeficiency, WHIM.
Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients https://t.co/FJFe0Xrsy5
A lot of us take our immune systems for granted. #COVID19#pandemic precautions - quarantining, masking, etc - gave us an example of how people with #PrimaryImmunodeficiency live every day, pre-COVID included. Join us to end the lifelong battle against illness for PI patients 💪
JMF Co-Founder Fred Modell shared this #joke for #NationalTellAJokeDay -
Patient: "I have a ringing in my ears."
Doctor: "Don't answer it!"
Spread some laughter today. Reply with your best joke! 😂
We proudly support research that creates a better understanding of Primary Immune Deficiency Disorders (#PIDDs) like WHIM, leading to better care & improved outcomes for patients. Thank you to all co-funders & congratulations to the authors on publishing this important work! 🥳
https://t.co/WONp9r6lgi
Excited to share our international cohort of 66 patients with #WHIMSyndrome (+11 novel CXCR4 variants). Our mission is early diagnosis and targeted therapy. We thank our global collaborators, patients, their families and supporters @Info4PI@X4Pharma
@X4Pharma@ChristophBGeier@WalterJolan Congratulations on publishing this important work on WHIM Syndrome! We are proud supporters of this research, which will lead to better disease management and improved outcomes for patients ♥
Congratulations @ChristophBGeier@WalterJolan & coauthors for their publication of research evaluating disease progression in an international cohort of #WHIM patients, identifying new genetic variants. Happy to support this research! @Info4PI Learn more: https://t.co/30T0v2VDdG